Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

10x Genomics (TXG) Asset Utilization Ratio (2019 - 2025)

10x Genomics' Asset Utilization Ratio history spans 7 years, with the latest figure at 0.62 for Q4 2025.

  • For Q4 2025, Asset Utilization Ratio fell 5.56% year-over-year to 0.62; the TTM value through Dec 2025 reached 0.62, down 5.56%, while the annual FY2025 figure was 0.66, 1.15% up from the prior year.
  • Asset Utilization Ratio for Q4 2025 was 0.62 at 10x Genomics, down from 0.64 in the prior quarter.
  • Across five years, Asset Utilization Ratio topped out at 0.69 in Q1 2025 and bottomed at 0.35 in Q1 2021.
  • The 5-year median for Asset Utilization Ratio is 0.59 (2023), against an average of 0.57.
  • The largest YoY upside for Asset Utilization Ratio was 61.06% in 2021 against a maximum downside of 18.67% in 2021.
  • A 5-year view of Asset Utilization Ratio shows it stood at 0.49 in 2021, then rose by 4.46% to 0.51 in 2022, then grew by 26.79% to 0.65 in 2023, then increased by 1.76% to 0.66 in 2024, then dropped by 5.56% to 0.62 in 2025.
  • Per Business Quant, the three most recent readings for TXG's Asset Utilization Ratio are 0.62 (Q4 2025), 0.64 (Q3 2025), and 0.68 (Q2 2025).